CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $318,000 | -28.1% | 23,300 | 0.0% | 0.13% | +6.5% |
| Q4 2015 | $442,000 | +1.1% | 23,300 | 0.0% | 0.12% | +47.6% |
| Q3 2015 | $437,000 | -89.3% | 23,300 | -91.5% | 0.08% | -78.3% |
| Q2 2015 | $4,102,000 | -5.3% | 275,500 | -3.7% | 0.39% | -5.4% |
| Q1 2015 | $4,333,000 | +10.7% | 286,100 | -2.6% | 0.41% | +9.1% |
| Q4 2014 | $3,913,000 | +5.6% | 293,800 | 0.0% | 0.38% | -1.8% |
| Q3 2014 | $3,705,000 | +13.4% | 293,800 | -9.2% | 0.38% | +35.9% |
| Q2 2014 | $3,268,000 | -24.4% | 323,600 | +0.7% | 0.28% | -20.4% |
| Q1 2014 | $4,320,000 | – | 321,200 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |